Enter any phrase or word you would like to search for and click .
PostNews
![BioStock: PHI charts a bold course to impact regenerative medicine](https://phiab.com/wp-content/uploads/2023/07/biostock-phi-interview-vision-320x180.jpg)
BioStock: PHI charts a bold course to impact regenerative medicine
BioStock contacted CEO Patrik Eschricht to delve into the year-end report’s highlights and shed light on the company’s vision and initiatives.
Learn more …
PostNews
![righst issue of units 2022 banner](https://phiab.com/wp-content/uploads/2022/03/AdobeStock_380349704-320x180.jpg)
BioStock: The five best life science stocks of the first half-year
PHI is proud to be highlighted as one of the top 5 best-performing Swedish life science stocks in the first half of 2023.
Learn more …
PostNews: Press Release
![Artistic image of molecularly imprinted polymers (MIP).](https://phiab.com/wp-content/uploads/2020/08/Molecularly-Imprinted-Polymers-MIP-320x180.jpg)
European Patent Office intends to grant PHI patent on synthetic antibodies
PHI AB announces today that the European Patent Office (EPO) intends to grant a patent on synthetic antibodies.
Learn more …
PostNews
![PHI-worldtour-1024x576](https://phiab.com/wp-content/uploads/2023/06/PHI-worldtour-1024x576-1-320x180.jpg)
BioStock: PHI’s CEO reflects on global roadshow success
BioStock contacted CEO Patrik Eschricht to learn about the team’s achievements on their global roadshow this early summer.
Learn more …
PostNews: Interim Report
![Well A2-1 2](https://phiab.com/wp-content/uploads/2023/05/Well-A2-1-2-320x180.jpg)
Interim Report 4 2022/23
Sales continue to grow, and the year ended up with the highest turnover for a year in PHI, so far.
Learn more …
PostNews: Press Release
Notice that Interim Report 4 2022/23 will be published on June 26, 2023
PHI changes the date for publication of Interim Report 4 2022/23 to June 26, 2023.
Learn more …